Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort.

2024

Eratne D, Li QX, Lewis C, Dang C, Kang MJY, Grewal J, Loi S, Walterfang M, Evans AH, Malpas CB, Pedrini S, Martins R, Chatterjee P, Zetterberg H, Blennow K, Berkovic SF, Santillo AF, Collins S, Masters CL, Velakoulis D; MiND Study Group.
J Neurol. 2024 Dec 12;272(1):25. doi: 10.1007/s00415-024-12732-3.PMID: 39666133